| Stereotactic Body Radiation Therapy, Tremelimumab and Durvalumab in Treating Participants With Recurrent or Metastatic Cervical, Vaginal, or Vulvar Cancers (NCT03452332) | M.D. Anderson Cancer Center | 2018-07-18 |
| STAT3 Inhibitor WP1066 in Treating Patients With Recurrent Malignant Glioma or Progressive Metastatic Melanoma in the Brain (NCT01904123) | M.D. Anderson Cancer Center | 2018-07-13 |
| An Investigational Scan (MR DENSE) in Detecting Early Chemotherapy-Related Liver Injury Before Surgery in Patients With Resectable Colorectal Liver Metastases (NCT05059717) | M.D. Anderson Cancer Center | 2018-07-12 |
| Pembrolizumab With Intratumoral Injection of Clostridium Novyi-NT (NCT03435952) | M.D. Anderson Cancer Center | 2018-07-10 |
| Self-monitoring Focus Groups With Vibrant Lives Pasadena Participants (NCT04611087) | M.D. Anderson Cancer Center | 2018-07-03 |
| Cemiplimab in Treating Patients With Recurrent and Resectable Stage II-IV Head and Neck Cutaneous Squamous Cell Cancer Before Surgery (NCT03565783) | M.D. Anderson Cancer Center | 2018-07-03 |
| Chemotherapy and/or Metastasectomy in Treating Patients With Metastatic Colorectal Adenocarcinoma With Lung Metastases (NCT03599752) | M.D. Anderson Cancer Center | 2018-07-02 |
| Pneumoperitoneum Management With Low vs. Higher Pressure (NCT03128281) | M.D. Anderson Cancer Center | 2018-07-01 |
| Trial Evaluating the Efficacy and Safety of Daratumumab in Subjects With Relapsed/Refractory B-cell or T-cell Precursor Acute Lymphoblastic Leukemia (ALL) (NCT03207542) | M.D. Anderson Cancer Center | 2018-07-01 |
| Physical Activity With or Without Dexamethasone in Reducing Cancer-Related Fatigue in Patients With Locally Advanced, Metastatic, or Recurrent Cancer (NCT03583255) | M.D. Anderson Cancer Center | 2018-06-29 |
| Venetoclax, Ponatinib, and Dexamethasone in Participants With Philadelphia Chromosome or BCR-ABL Positive Relapsed or Refractory Acute Lymphoblastic Leukemia or Chronic Myelogenous Leukemia (NCT03576547) | M.D. Anderson Cancer Center | 2018-06-26 |
| Barriers Affecting Physical Activity (NCT03573375) | M.D. Anderson Cancer Center | 2018-06-20 |
| Standard and Delayed FDG PET/CT After Chemoradiation Therapy in Assessing Patients With Metastatic Head and Neck Squamous Cell Cancer (NCT03575949) | M.D. Anderson Cancer Center | 2018-06-15 |
| Stereotactic Body Radiation Therapy in Treating Patients With Oligometastatic Renal Cell Carcinoma (NCT03575611) | M.D. Anderson Cancer Center | 2018-06-14 |
| M7824 and Eribulin Mesylate in Treating Patients With Metastatic Triple Negative Breast Cancer (NCT03579472) | M.D. Anderson Cancer Center | 2018-05-30 |
| Daratumumab in Treating Patients with Muscle Invasive Bladder Cancer or Metastatic Kidney Cancer (NCT03473730) | M.D. Anderson Cancer Center | 2018-05-29 |
| Phase II Trial of Nivolumab Plus Ipilimumab in Patients With Renal Medullary Carcinoma (NCT03274258) | M.D. Anderson Cancer Center | 2018-05-29 |
| Monitoring Your Exercise-related Metrics Over Time Via Wearable Electronic Devices (NCT05124405) | M.D. Anderson Cancer Center | 2018-05-24 |
| Ibrutinib as Early Therapy in Chronic Lymphocytic Leukemia (CLL) (NCT03207555) | M.D. Anderson Cancer Center | 2018-05-23 |
| Levocarnitine and Vitamin B Complex in Treating PEG-Asparaginase or Inotuzumab Ozogamicin-Induced Hyperbilirubinemia in Patients With Acute Lymphoblastic Leukemia (NCT03564678) | M.D. Anderson Cancer Center | 2018-05-17 |
| Comparative Study To Determine The Efficacy, Safety, And Tolerability Of Ceftolozane-Tazobactam (NCT03485950) | M.D. Anderson Cancer Center | 2018-05-16 |
| Cabozantinib or Sunitinib Malate in Treating Participants With Metastatic Variant Histology Renal Cell Carcinoma (NCT03541902) | M.D. Anderson Cancer Center | 2018-05-15 |
| PET/MR Versus CECT Scans in Imaging Patients With Ovarian Cancer or Highly Suspected Ovarian Cancer (NCT03965481) | M.D. Anderson Cancer Center | 2018-05-12 |
| Intravenous and Intrathecal Nivolumab in Treating Patients With Leptomeningeal Disease (NCT03025256) | M.D. Anderson Cancer Center | 2018-05-02 |
| MEDI4736 With Selumetinib for KRAS Mutant Non-Small Cell Lung Cancer (NSCLC) (NCT03004105) | M.D. Anderson Cancer Center | 2018-05-01 |
| Phase II Study of Fludarabine, Cytarabine (ARA-C) and Erwinase IV in Patients With Relapsed or Refractory Hematologic Malignancies (NCT02718755) | M.D. Anderson Cancer Center | 2018-05-01 |
| Radiation Therapy and M7824 in Treating Patients With Metastatic Hormone Receptor Positive, HER2 Negative Breast Cancer (NCT03524170) | M.D. Anderson Cancer Center | 2018-04-30 |
| Radial-Probe Endobronchial Ultrasound in Detecting Atelectasis in Patients Undergoing Peripheral Bronchoscopy (NCT03523689) | M.D. Anderson Cancer Center | 2018-04-30 |
| LN-145 or LN-145-S1 in Treating Patients With Relapsed or Refractory Ovarian Cancer, Triple Negative Breast Cancer (TNBC), Anaplastic Thyroid Cancer, Osteosarcoma, or Other Bone and Soft Tissue Sarcomas (NCT03449108) | M.D. Anderson Cancer Center | 2018-04-27 |
| Use of a Smartphone Mobile Application (App) to Enhance Smoking Cessation Treatment (NCT03519451) | M.D. Anderson Cancer Center | 2018-04-25 |
| A Prospective Study of Performing MRI Simulation in Treatment Position in Spinal Stereotactic Body Radiation Therapy (NCT05155423) | M.D. Anderson Cancer Center | 2018-04-21 |
| Low-Intensity Chemotherapy and Blinatumomab in Treating Patients With Philadelphia Chromosome Negative Relapsed or Refractory Acute Lymphoblastic Leukemia (NCT03518112) | M.D. Anderson Cancer Center | 2018-04-18 |
| Developing an eLearning Program in Helping Spanish and Portuguese Speaking Cancer Care Providers During Tobacco Use Counselling (NCT03539991) | M.D. Anderson Cancer Center | 2018-04-18 |
| Utomilumab and ISA101b Vaccination in Patients With HPV-16-Positive Incurable Oropharyngeal Cancer (NCT03258008) | M.D. Anderson Cancer Center | 2018-04-04 |
| Cycling in Preventing Colorectal Cancer in Participants With Lynch Syndrome (NCT03495674) | M.D. Anderson Cancer Center | 2018-04-04 |
| Trial of Quercetin in the Treatment and Prevention of Chemotherapy-induced Neuropathic Pain in Cancer Patients (NCT02989129) | M.D. Anderson Cancer Center | 2018-04-01 |
| Combination Chemotherapy and Inotuzumab Ozogamicin in Treating Patients With B Acute Lymphoblastic Leukemia (NCT03488225) | M.D. Anderson Cancer Center | 2018-03-28 |
| Apalutamide in Treating Patients With Prostate Cancer Before Radical Prostatectomy (NCT03412396) | M.D. Anderson Cancer Center | 2018-03-22 |
| Study of Durvalumab (MEDI4736) (Anti-PD-L1) and Trametinib (MEKi) in MSS Metastatic Colon Cancer (NCT03428126) | M.D. Anderson Cancer Center | 2018-03-21 |
| Ivosidenib and Venetoclax With or Without Azacitidine in Treating Patients With IDH1 Mutated Hematologic Malignancies (NCT03471260) | M.D. Anderson Cancer Center | 2018-03-19 |
| Continuous Positive Airway Pressure Device or Deep Inspiration Breath Hold in Reducing Tumor Motion in Patients Undergoing Stereotactic Body Radiation Therapy for Lung Cancer (NCT03422302) | M.D. Anderson Cancer Center | 2018-03-16 |
| Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease (NCT03425526) | M.D. Anderson Cancer Center | 2018-03-15 |
| Sapanisertib and Metformin in Treating Patients With Advanced or Metastatic Relapsed or Refractory Cancers (NCT03017833) | M.D. Anderson Cancer Center | 2018-03-12 |
| Sapanisertib, Carboplatin, and Paclitaxel in Treating Patients With Recurrent or Refractory Malignant Solid Tumors (NCT03430882) | M.D. Anderson Cancer Center | 2018-03-12 |
| Indwelling Pleural Catheters With or Without Doxycycline in Treating Patients With Malignant Pleural Effusions (NCT03465774) | M.D. Anderson Cancer Center | 2018-03-08 |
| M7824 in Patients With Metastatic Colorectal Cancer or With Advanced Solid Tumors With Microsatellite Instability (NCT03436563) | M.D. Anderson Cancer Center | 2018-03-07 |
| Apalutamide, Abiraterone Acetate, and Prednisone in Treating Participants With Metastatic Castration Resistant Prostate Cancer (NCT03360721) | M.D. Anderson Cancer Center | 2018-03-06 |
| Dose Escalation and Cohort Expansion of Safety and Tolerability Study of Intratumoral rAd.CD40L (ISF35) in Combination of Systemic Pembrolizumab in Patients With Refractory Metastatic Melanoma (NCT02719015) | M.D. Anderson Cancer Center | 2018-03-01 |
| Study of Brentuximab Vedotin Plus TAK228 for Relapsed/Refractory Classical Hodgkin Lymphoma, Anaplastic Large Cell Lymphoma and Other CD30+Peripheral T-Cell Lymphomas (NCT03205891) | M.D. Anderson Cancer Center | 2018-03-01 |
| Cabozantinib in Treating Patients With Locally Advanced or Metastatic Unresectable Adrenocortical Carcinoma (NCT03370718) | M.D. Anderson Cancer Center | 2018-02-26 |
| Chemotherapy With or Without Radiation or Surgery in Treating Participants With Oligometastatic Esophageal or Gastric Cancer (NCT03161522) | M.D. Anderson Cancer Center | 2018-02-19 |
| Neratinib and Paclitaxel With or Without Pertuzumab and Trastuzumab Before Combination Chemotherapy in Treating Patients With Metastatic or Locally Advanced Breast Cancer (NCT03101748) | M.D. Anderson Cancer Center | 2018-02-19 |
| Inotuzumab Ozogamicin in Treating Patients With B-cell Acute Lymphocytic Leukemia With Positive Minimal Residual Disease (NCT03441061) | M.D. Anderson Cancer Center | 2018-02-15 |
| REVOLVE or PureGraft Technique in Processing Fat Grafts for Patients Undergoing Breast Reconstruction (NCT03502512) | M.D. Anderson Cancer Center | 2018-02-13 |
| Pembrolizumab in Treating Patients With Metastatic or Unresectable Gastroesophageal Adenocarcinoma (NCT03395847) | M.D. Anderson Cancer Center | 2018-02-09 |
| Low-Intensity Chemotherapy, Ponatinib and Blinatumomab in Treating Patients With Philadelphia Chromosome-Positive and/or BCR-ABL Positive Acute Lymphoblastic Leukemia (NCT03147612) | M.D. Anderson Cancer Center | 2018-02-08 |
| Daratumumab, Ixazomib, and Dexamethasone in AL Amyloidosis (NCT03283917) | M.D. Anderson Cancer Center | 2018-02-07 |
| Trametinib and Pembrolizumab in Treating Patients With Recurrent Non-small Cell Lung Cancer That Is Metastatic, Unresectable, or Locally Advanced (NCT03225664) | M.D. Anderson Cancer Center | 2018-02-03 |
| Pembrolizumab and External Beam Radiation Therapy in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma (NCT03210662) | M.D. Anderson Cancer Center | 2018-02-01 |
| Combination Chemotherapy, Total Body Irradiation, and Donor Blood Stem Cell Transplant in Treating Patients With Primary or Secondary Myelofibrosis (NCT03426969) | M.D. Anderson Cancer Center | 2018-01-31 |
| Afimoxifene in Reducing the Risk of Breast Cancer in Women With Mammographically Dense Breast (NCT03063619) | M.D. Anderson Cancer Center | 2018-01-30 |
| Watchful Living in Improving Quality of Life in Participants With Localized Prostate Cancer on Active Surveillance and Their Partners (NCT03575832) | M.D. Anderson Cancer Center | 2018-01-25 |
| Venetoclax and Decitabine in Treating Participants With Relapsed/Refractory Acute Myeloid Leukemia or Relapsed High-Risk Myelodysplastic Syndrome (NCT03404193) | M.D. Anderson Cancer Center | 2018-01-18 |
| Trial of Magnetic Resonance Imaging Guided Radiotherapy Dose Adaptation in Human Papilloma Virus Positive Oropharyngeal Cancer (NCT03224000) | M.D. Anderson Cancer Center | 2018-01-17 |
| Osimertinib, Surgery, and Radiation Therapy in Treating Patients With Stage IIIB or IV Non-small Cell Lung Cancer With EGFR Mutations, NORTHSTAR Study (NCT03410043) | M.D. Anderson Cancer Center | 2018-01-17 |
| Azacitidine and Enasidenib in Treating Patients With IDH2-Mutant Myelodysplastic Syndrome (NCT03383575) | M.D. Anderson Cancer Center | 2018-01-17 |
| Contrast Enhanced Ultrasound With Lumason in Detecting Liver Cancer in Participants With Cirrhosis (NCT03407001) | M.D. Anderson Cancer Center | 2018-01-12 |
| Measurement of Adherence and Health-Related Quality of Life, and Health-Care Resource Utilization (NCT03407469) | M.D. Anderson Cancer Center | 2018-01-12 |
| Pembrolizumab in Treating Patients With Bladder Cancer Undergoing Radical Cystectomy (NCT03319745) | M.D. Anderson Cancer Center | 2018-01-11 |
| Rapid On Site Evaluation of Pleural Touch Preparations in Diagnosing Malignant Pleural Effusion in Patients Undergoing Pleuroscopy (NCT03868579) | M.D. Anderson Cancer Center | 2018-01-10 |
| Ultra Low Dose Radiation Therapy in Treating Patients With Mycosis Fungoides (NCT03398161) | M.D. Anderson Cancer Center | 2018-01-06 |
| Nivolumab and Ipilimumab With or Without Local Consolidation Therapy in Treating Patients With Stage IV Non-Small Cell Lung Cancer (NCT03391869) | M.D. Anderson Cancer Center | 2017-12-29 |
| Panitumumab With or Without Trametinib in Treating Patients With Stage IV Colorectal Cancer (NCT03087071) | M.D. Anderson Cancer Center | 2017-12-29 |
| Acceptability of 3D Printed Breast Models as Surgical Decision Aids for Breast Cancer Treatment (NCT04693364) | M.D. Anderson Cancer Center | 2017-12-27 |
| Utomilumab, Cetuximab, and Irinotecan Hydrochloride in Treating Patients With Metastatic Colorectal Cancer (NCT03290937) | M.D. Anderson Cancer Center | 2017-12-27 |
| OX40, Venetoclax, Avelumab, Glasdegib, Gemtuzumab Ozogamicin, and Azacitidine in Relapsed or Refractory Acute Myeloid Leukemia (NCT03390296) | M.D. Anderson Cancer Center | 2017-12-27 |
| A Survey of Parent/Caregiver Practices on the Storage, Use, and Disposal of Opioids in a Comprehensive Cancer Center (NCT03390283) | M.D. Anderson Cancer Center | 2017-12-20 |
| Efficacy of Ferric Carboxymaltose in Gastrointestinal Stromal Tumor (GIST) Patients With Iron Deficiency Anemia (IDA) Receiving Systemic Therapy (NCT02949947) | M.D. Anderson Cancer Center | 2017-12-18 |
| Diabetes Prevention Program With or Without Hunger Training in Helping to Lower Breast Cancer Risk in Obese Participants (NCT03546972) | M.D. Anderson Cancer Center | 2017-12-17 |
| Difference in the Estimation of Prognosis (NCT03115528) | M.D. Anderson Cancer Center | 2017-12-14 |
| Pembrolizumab in Treating Participants With Unresectable Thymoma or Thymic Cancer (NCT03295227) | M.D. Anderson Cancer Center | 2017-12-06 |
| An Early Stress-Reduction Intervention in Patients With Newly Diagnosed Breast Cancer (NCT03429907) | M.D. Anderson Cancer Center | 2017-12-05 |
| Dexamethasone in Controlling Dyspnea in Patients With Cancer (NCT03367156) | M.D. Anderson Cancer Center | 2017-12-04 |
| Inotuzumab Ozogamicin in Treating Patients With Relapsed or Refractory CD22 Positive Acute Lymphoblastic Leukemia (NCT03094611) | M.D. Anderson Cancer Center | 2017-11-30 |
| Ambu AuraGain and Teleflex LMA Protector Fiberoptic Assessments in Elective Patients (NCT02724956) | M.D. Anderson Cancer Center | 2017-11-29 |
| Blinatumomab, Methotrexate, Cytarabine, and Ponatinib in Treating Patients With Philadelphia Chromosome-Positive, or BCR-ABL Positive, or Relapsed/Refractory, Acute Lymphoblastic Leukemia (NCT03263572) | M.D. Anderson Cancer Center | 2017-11-29 |
| Four Quadrants Transverse Abdominus Plane (4Q-TAP) Block With Plain and Liposomal Bupivacaine vs. Thoracic Epidermal Analgesia (TEA) in Patients Undergoing Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC) on an Enhanced Recovery Pathway (NCT03359811) | M.D. Anderson Cancer Center | 2017-11-27 |
| Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases (NCT03093909) | M.D. Anderson Cancer Center | 2017-11-22 |
| Questionnaires in Assessing Attitudes About Legalization of Marijuana Use in Participants With Cancer (NCT03360799) | M.D. Anderson Cancer Center | 2017-11-17 |
| Neuromuscular Blockade on Shoulder Pain of Elderly (NCT03210376) | M.D. Anderson Cancer Center | 2017-11-17 |
| PREVENT: PeRomEter Visualization to ENd Treatment-related Lymphedema (NCT05056207) | M.D. Anderson Cancer Center | 2017-11-17 |
| Radiation Therapy Before Surgery in Treating Patients With Hormone Receptor Positive, HER2 Negative Breast Cancer (NCT03359954) | M.D. Anderson Cancer Center | 2017-11-16 |
| Glutaminase Inhibitor CB-839 and Azacitidine in Treating Patients With Advanced Myelodysplastic Syndrome (NCT03047993) | M.D. Anderson Cancer Center | 2017-11-15 |
| Study of Pembrolizumab (MK-3475) in Combination With Romidepsin (NCT03278782) | M.D. Anderson Cancer Center | 2017-11-14 |
| IACS-010759 in Advanced Cancers (NCT03291938) | M.D. Anderson Cancer Center | 2017-11-13 |
| Laser Interstitial Thermal Therapy and Lomustine in Treating Patients With Recurrent Glioblastoma or Anaplastic Astrocytoma (NCT03022578) | M.D. Anderson Cancer Center | 2017-11-07 |
| Azacitidine and Pembrolizumab in Treating Patients With Myelodysplastic Syndrome (NCT03094637) | M.D. Anderson Cancer Center | 2017-11-06 |
| Neratinib and Everolimus, Palbociclib, or Trametinib in Treating Participants With Refractory and Advanced or Metastatic Solid Tumors With EGFR Mutation/Amplification, HER2 Mutation/Amplification, or HER3/4 Mutation or KRAS Mutation (NCT03065387) | M.D. Anderson Cancer Center | 2017-10-31 |
| Daratumumab in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome (NCT03067571) | M.D. Anderson Cancer Center | 2017-10-27 |
| Study of Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) in Patients With Gastric Adenocarcinoma and Carcinomatosis or Positive Cytology (NCT03330028) | M.D. Anderson Cancer Center | 2017-10-27 |